Excessive sleep associated with longer time to return to work among colorectal cancer survivors
the ONA take:
Excessive sleep was associated with a longer time to return to work, a reduction in work time, and increased likelihood to retire among colorectal cancer survivors, according to a recent study published online ahead of print in the journal Supportive Care in Cancer.
For the study, researchers in Australia enrolled 239 colorectal cancer survivors in order to assess associations of health behaviors with return to work outcomes following a colorectal cancer diagnosis among men and women aged 45 to 64 years. Participants were interviewed via telephone and answered questionnaires at 6 and 12 months following diagnosis.
Results showed that participants who reported sleeping 9 or more hours per day were 2.69 times more likely to decrease work time or retire compared with those who slept between 7 and 9 hours per day. Researchers found that excessive sleep was also associated with a longer time to returning to work.
The findings suggest that interventions designed to help colorectal cancer survivors achieve optimal sleep may help them return to work sooner. Further studies are warranted to test those interventions.
Excessive sleep was associated with a longer time to return to work, a reduction in work time, and increased likelihood to retire.
- Novel Colonoscopy Prep Is Poised to Improve Screening Rates for Colon Cancer
- PPIs Negatively Impact Outcomes of Patients Treated With Capecitabine
- How Physical Changes From Breast Cancer Affect Self-Image: Considerations for Clinicians
- Clinical Use of Cabozantinib in the Treatment of Advanced Kidney Cancer: Efficacy, Safety, and Patient Selection
- Panobinostat Modestly Improves OS in Relapsed Multiple Myeloma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Pseudohyperkalemia: False Potassium Levels Occur in a Patient With Lymphoma
- Atezolizumab Granted FDA Approval for Specific Cases of NSCLC
- Low-Dose Sublingual Fentanyl Safe, Effective in Patients Receiving Lower Opioid Doses
- High U.S. Economic Burden for Vaccine-Preventable Diseases
- Short-Term Intervention May Have Long-term Diet Effect in Hispanic Breast Cancer Survivors
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|